JeffreySchneiderMD

PubMed

• 1 citations
  6-Mercaptopurine and Macrophage Activation Syndrome Case Report and Review of the Literature.
  Lilia Davenport, Jamie Chin-Hon, Juri Chung, Xian Jie Cindy Chen, Jeffrey Schneider> ;Journal of Pharmacy Practice. 2023 Aug 1
• 11 citations
  Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (M...
  Edward B. Garon, Byoung Chul Cho, Niels Reinmuth, Ki Hyeong Lee, Alexander Luft, Myung-Ju Ahn, Gilles Robinet, Sylvestre Le Moulec, Ronald B. Natale, Jeffrey Gary Schn...> ;Clinical Lung Cancer. 2021 Feb 19
• 2 citations
  Considerations for the Management of Oncology Patients During the COVID-19 Pandemic
  Julie Huang, Abhinav Rohatgi, Jeffrey Schneider, Marc Justin Braunstein> ;Oncology. 2020 Oct 9
• 384 citations
  Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinic...
  Naiyer A. Rizvi, Byoung Chul Cho, Niels Reinmuth, Ki Hyeong Lee, Alexander Luft, Myung-Ju Ahn, Michel M. van den Heuvel, M. Cobo, David Vicente, Alexey Smolin, Vladimi...> ;JAMA Oncology. 2020 May 1
• 210 citations
  Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
  Neal Ready, Anna F. Farago, Filippo de Braud, Akin Atmaca, Matthew D. Hellmann, Jeffrey Gary Schneider, David R. Spigel, Victor Moreno, Ian Chau, Christine L. Hann, Jo...> ;Journal of Thoracic Oncology. 2019 Feb 1
• Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer.
  Long, G. V.,Tykodi, S. S.,Schneider, J. G.,Garbe, C.,Gravis, G.,Rashford, M.,Agrawal, S.,Grigoryeva, E.,Bello, A.,Roy, A.,Rollin, L.,Zhao, X.> ;Ann. Oncol.. 2018 Sep 15
• 34 citations
  A Retrospective Review of CyberKnife Stereotactic Body Radiotherapy for Adrenal Tumors (Primary and Metastatic): Winthrop University Hospital Experience
  Amishi Desai, Hema Rai, Jonathan A. Haas, Matthew Witten, S.R. Blacksburg, Jeffrey Gary Schneider> ;Frontiers in Oncology. 2015 Aug 17
• 7 citations
  Stereotactic body radiation therapy for stage I non-small cell lung cancer: a small academic hospital experience.
  Oren B. Factor, Charles C. Vu, Matthew Witten, Scott L. Schubach, Alicia E. Gittleman, D. Catell, Jonathan A. Haas, Jeffrey Gary Schneider> ;Frontiers in Oncology. 2014 Oct 20
• 15 citations
  Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use
  Jeffrey Gary Schneider, Danny N. Khalil> ;Breast Cancer Research and Treatment. 2012 Jun 22
• Join now to see all